Patent details

Basic Information

Publication number:

EP3068411

PCT Application Number:

CA2014000806

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148616253

PCT Publication Number:

WO2015070323

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ONCOLYTIC VIRUSES AND INCREASED CANCER TREATMENT REGIMENS

French Title of Invention:

VIRUS ONCOLYTIQUES ET SCHÉMAS POSOLOGIQUES DE TRAITEMENT DU CANCER RENFORCÉS

German Title of Invention:

ONKOLYTISCHE VIREN UND WIRKSAMERE KREBSBEHANDLUNGSSCHEMATA

SPC Number:

Dates

Filing date:

12/11/2014

Grant date:

18/03/2020

EP Publication Date:

21/09/2016

PCT Publication Date:

21/05/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/03/2020

EP B1 Publication Date:

18/03/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/11/2020

Expiration date:

12/11/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/03/2020

 

 

Name:

Oncolytics Biotech Inc.

Address:

Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)

Inventor

1

Name:

COFFEY, Matthew C.

Address:

Canada (CA)

2

Name:

THOMPSON, Bradley G.

Address:

Canada (CA)

Priority

Priority Number:

201361904783 P

Priority Date:

15/11/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/337; A61K 31/555; A61P 35/00; A61K 35/76; A61K 35/765; A61K 35/768;

Publication

European Patent Bulletin

Issue number:

202012

Publication date:

18/03/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages